Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-21 5:57 pm Purchase |
2025-02-13 | 13G | Edgewise Therapeutics, Inc. EWTX |
PERCEPTIVE ADVISORS LLC | 5,164,487 5.500% |
5,164,487 (New Position) |
Filing History |
| 2025-02-14 11:24 am Purchase |
2024-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
JANUS HENDERSON GROUP PLC JHG |
4,983,940 5.300% |
4,983,940 (New Position) |
Filing History |
| 2025-02-03 4:36 pm Purchase |
2025-01-27 | 13G | Edgewise Therapeutics, Inc. EWTX |
Paradigm BioCapital Advisors LP | 4,738,929 5.000% |
4,738,929 (New Position) |
Filing History |
| 2024-11-14 6:22 pm Sale |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
EcoR1 Capital LLC | 1,250,385 1.300% |
-2,242,809 (-64.21%) |
Filing History |
| 2024-11-14 4:31 pm Sale |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
VIKING GLOBAL INVESTORS LP | 1,481,146 1.600% |
-4,678,000 (-75.95%) |
Filing History |
| 2024-11-14 4:14 pm Purchase |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
Baker Bros. Advisors LP | 5,840,059 6.200% |
5,840,059 (New Position) |
Filing History |
| 2024-11-14 08:59 am Sale |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 1,781,006 1.900% |
-2,697,586 (-60.23%) |
Filing History |
| 2024-11-12 5:23 pm Unchanged |
2024-11-07 | 13D | Edgewise Therapeutics, Inc. EWTX |
ORBIMED ADVISORS LLC | 14,756,096 15.600% |
0 (Unchanged) |
Filing History |
| 2024-11-12 09:55 am Sale |
2024-11-08 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 653,207 0.696% |
-4,127,355 (-86.34%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
BLACKROCK INC BLK |
6,393,567 6.800% |
0 (Unchanged) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
BLACKROCK INC BLK |
6,393,567 6.800% |
2,888,368 (+82.40%) |
Filing History |
| 2024-09-23 9:20 pm Sale |
2024-09-19 | 13D | Edgewise Therapeutics, Inc. EWTX |
Novo Holdings A/S | 5,549,900 5.900% |
-794,530 (-12.52%) |
Filing History |
| 2024-07-10 10:10 am Sale |
2024-07-09 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 4,780,562 5.118% |
-1,711,951 (-26.37%) |
Filing History |
| 2024-02-14 10:26 am Purchase |
2023-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
VIKING GLOBAL INVESTORS LP | 6,159,146 9.700% |
1,750,000 (+39.69%) |
Filing History |
| 2024-02-14 08:43 am Sale |
2023-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
Deep Track Capital, LP | 2,537,176 4.000% |
-837,218 (-24.81%) |
Filing History |
| 2024-02-09 09:03 am Sale |
2024-02-08 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 6,492,513 10.230% |
-2,096,716 (-24.41%) |
Filing History |
| 2024-02-07 5:09 pm Purchase |
2024-01-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
BLACKROCK INC BLK |
3,505,199 4.100% |
198,089 (+5.99%) |
Filing History |
| 2024-02-02 3:57 pm Purchase |
2023-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
BLACKROCK INC BLK |
3,307,110 5.200% |
3,307,110 (New Position) |
Filing History |
| 2024-02-01 5:28 pm Purchase |
2024-01-23 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 4,478,592 5.250% |
545,455 (+13.87%) |
Filing History |
| 2024-01-29 4:30 pm Purchase |
2024-01-19 | 13G | Edgewise Therapeutics, Inc. EWTX |
RA Capital Management, L.P. | 8,909,091 9.600% |
8,909,091 (New Position) |
Filing History |